文献速递血脂与心血管预防

启动他汀后胆固醇反应欠佳与未来心血管疾病风险

Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease.
PubMed 文献 · Heart · 2019-04-15

24个月内LDL-C降幅<40%定义为反应欠佳,84 609例(51.2%)属此列;随访中位6.2年,反应欠佳者心血管事件风险显著升高(校正HR 1.17,95%CI 1.13–1.20)。

要点

  • 超过半数患者在启动他汀2年内未达到LDL-C降幅≥40%的目标
  • LDL-C反应欠佳者未来心血管事件风险显著升高(校正HR 1.17)
  • 启动他汀后应复查LDL-C以评估反应并考虑强化治疗

核心结论

  • 在普通人群中启动他汀治疗的患者,超过半数在2年内未达到最佳LDL-C降幅,其未来心血管疾病风险显著增加。

研究设计与样本

  • 英国临床实践研究数据链的前瞻性队列研究,纳入165 411例启动他汀前无心血管疾病的基层患者,要求启动前12个月内有至少一次未治疗LDL-C、启动后24个月内有至少一次LDL-C检测。
  • 以24个月内LDL-C较基线降幅<40%定义为反应欠佳,采用Cox比例回归和竞争风险生存回归模型分析。

主要发现

  • 84 609例(51.2%)患者在启动他汀24个月内LDL-C反应欠佳。
  • 随访共1 077 299人年(中位随访6.2年),发生22 798例心血管事件,其中反应欠佳者12 142例、反应良好者10 656例。
  • 反应欠佳者相较反应良好者,心血管事件HR为1.17(95%CI 1.13–1.20);校正年龄和基线未治疗LDL-C后HR为1.22(95%CI 1.19–1.25)。
  • 考虑竞争风险后,未校正sub-HR为1.13(95%CI 1.10–1.16),校正后sub-HR为1.19(95%CI 1.16–1.23)。

关键数值与推荐

  • LDL-C反应欠佳定义为启动他汀24个月内LDL-C较基线降幅<40%(依据现行国家指南)。

临床怎么用

  • 启动他汀后应在24个月内复查LDL-C评估降幅是否达到≥40%,未达标者需考虑强化降脂治疗以降低未来心血管风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess low-density lipoprotein cholesterol (LDL-C) response in patients after initiation of statins, and future risk of cardiovascular disease (CVD). METHODS: Prospective cohort study of 165 411 primary care patients, from the UK Clinical Practice Research Datalink, who were free of CVD before statin initiation, and had at least one pre-treatment LDL-C within 12 months before, and one post-treatment LDL-C within 24 months after, statin initiation. Based on current national guidelines, <40% reduction in baseline LDL-C within 24 months was classified as a sub-optimal statin response. Cox proportional regression and competing-risks survival regression models were used to determine adjusted hazard ratios (HRs) and sub-HRs for incident CVD outcomes for LDL-C response to statins. RESULTS: 84 609 (51.2%) patients had a sub-optimal LDL-C response to initiated statin therapy within 24 months. During 1 077 299 person-years of follow-up (median follow-up 6.2 years), there were 22 798 CVD events (12 142 in sub-optimal responders and 10 656 in optimal responders). In sub-optimal responders, compared with optimal responders, the HR for incident CVD was 1.17 (95% CI 1.13 to 1.20) and 1.22 (95% CI 1.19 to 1.25) after adjusting for age and baseline untreated LDL-C. Considering competing risks resulted in lower but similar sub-HRs for both unadjusted (1.13, 95% CI 1.10 to 1.16) and adjusted (1.19, 95% CI 1.16 to 1.23) cumulative incidence function of CVD. CONCLUSIONS: Optimal lowering of LDL-C is not achieved within 2 years in over half of patients in the general population initiated on statin therapy, and these patients will experience significantly increased risk of future CVD.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Akyea RK, Kai J, Qureshi N, et al. Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease. Heart. 2019. PMID: 30988003. doi:10.1136/heartjnl-2018-314253

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。